{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T06:33:01Z","timestamp":1777789981306,"version":"3.51.4"},"reference-count":26,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slovenian research agency (ARRS)","award":["J3-1750"],"award-info":[{"award-number":["J3-1750"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The aim of the study was to determine the rate of retinal degeneration in patients with c.2610C&gt;A (p.Cys870*) in USH2A exon 13, amenable to exon skipping therapy. There were nine patients from seven families, three of whom were male (two were homozygous). Seven patients had follow-up data (median of 11 years). Analysis included best corrected visual acuity (BCVA, decimal Snellen), visual field (Goldmann perimetry target II\/4), fundus autofluorescence (FAF), optical coherence tomography (OCT), and microperimetry (MP). The median age at the onset of nyctalopia was 20 years (range, 8\u201335 years of age). At the first exam, at a median age of 42 years, the median BCVA was 0.5 (0.2\u20131.0), and the median visual field diameter was 23\u00b0 (5\u00b0\u2013114\u00b0). Imaging showed a hyperautofluorescent ring delineating preserved foveal photoreceptors in 78% (7\/9) of patients, while 22% (2\/9) had a hyperautofluorescent patch or atrophy, reflecting advanced disease. Survival analysis predicted that 50% of patients reach legal blindness based on a visual field diameter &lt; 20\u00b0 at the age of 52 (95% CI, 45\u201359) and legal blindness based on a BCVA \u2264 0. 1 (20\/200) at the age of 55 (95% CI, 46\u201366). Visual field constriction occurred at the median rate of radial 1.5 deg\/year, and hyperautofluorescent ring constriction occurred at the median rate of 34 \u03bcm\/year. A non-null second allele was found in two patients: p.Thr4315Pro and p.Arg303His; the patient with p.Arg303His had a milder disease. The rates of progression will be useful in the design and execution of clinical trials.<\/jats:p>","DOI":"10.3390\/genes14030652","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T05:18:43Z","timestamp":1678079923000},"page":"652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural Disease Course in Usher Syndrome Patients Harboring USH2A Variant p.Cys870* in Exon 13, Amenable to Exon Skipping Therapy"],"prefix":"10.3390","volume":"14","author":[{"given":"Katja","family":"\u010cadoni\u010d","sequence":"first","affiliation":[{"name":"Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1982-7572","authenticated-orcid":false,"given":"Jana","family":"Sajovic","sequence":"additional","affiliation":[{"name":"Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Hawlina","sequence":"additional","affiliation":[{"name":"Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Fakin","sequence":"additional","affiliation":[{"name":"Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/WCO.0b013e32834ef8b2","article-title":"Usher syndrome (sensorineural deafness and retinitis pigmentosa): Pathogenesis, molecular diagnosis and therapeutic approaches","volume":"25","author":"Bonnet","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/14992020600975279","article-title":"The changing face of Usher syndrome: Clinical implications","volume":"46","author":"Cohen","year":"2007","journal-title":"Int. J. Audiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1073\/pnas.0610950104","article-title":"Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells","volume":"104","author":"Liu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/jhg.2010.29","article-title":"Genetics and pathological mechanisms of Usher syndrome","volume":"55","author":"Yan","year":"2010","journal-title":"J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbadis.2014.11.020","article-title":"Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities","volume":"1852","author":"Mathur","year":"2015","journal-title":"Biochim. Biophys Acta"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2013.11.001","article-title":"Usher protein functions in hair cells and photoreceptors","volume":"46","author":"Cosgrove","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108330","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-retinopathy: From genetics to therapeutics","volume":"201","author":"Toualbi","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Falsini, B., Placidi, G., De Siena, E., Savastano, M.C., Minnella, A.M., Maceroni, M., Midena, G., Ziccardi, L., Parisi, V., and Bertelli, M. (2021). USH2A-Related Retinitis Pigmentosa: Staging of Disease Severity and Morpho-Functional Studies. Diagnostics, 11.","DOI":"10.3390\/diagnostics11020213"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","article-title":"Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations","volume":"29","author":"Dulla","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Fakin, A., \u0160u\u0161tar, M., Brecelj, J., Bonnet, C., Petit, C., Zupan, A., Glava\u010d, D., Jarc-Vidmar, M., Battelino, S., and Hawlina, M. (2019). Double Hyperautofluorescent Rings in Patients with USH2A-Retinopathy. Genes, 10.","DOI":"10.3390\/genes10120956"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.visres.2012.08.017","article-title":"Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2","volume":"75","author":"Fakin","year":"2012","journal-title":"Vis. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1167\/iovs.08-2009","article-title":"Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene","volume":"49","author":"Sandberg","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fakin, A., Bonnet, C., Kurtenbach, A., Mohand-Said, S., Zobor, D., Stingl, K., Testa, F., Simonelli, F., Sahel, J.A., and Audo, I. (2021). Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910352"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2016.01.021","article-title":"Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa","volume":"123","author":"Pierrache","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Carro, R., Blanco-Kelly, F., Galbis-Mart\u00ednez, L., Garc\u00eda-Garc\u00eda, G., Aller, E., Garc\u00eda-Sandoval, B., M\u00ednguez, P., Corton, M., Mah\u00edllo-Fern\u00e1ndez, I., and Mart\u00edn-M\u00e9rida, I. (2018). Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199048"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Comander, J., Weigel-DiFranco, C., Maher, M., Place, E., Wan, A., Harper, S., Sandberg, M.A., Navarro-Gomez, D., and Pierce, E.A. (2017). The Genetic Basis of Pericentral Retinitis Pigmentosa\u2014A Form of Mild Retinitis Pigmentosa. Genes, 8.","DOI":"10.3390\/genes8100256"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zupan, A., Fakin, A., Battelino, S., Jarc-Vidmar, M., Hawlina, M., Bonnet, C., Petit, C., and Glava\u010d, D. (2019). Clinical and Haplotypic Variability of Slovenian USH2A Patients Homozygous for the c. 11864G>A Nonsense Mutation. Genes, 10.","DOI":"10.3390\/genes10121015"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ophtha.2013.09.017","article-title":"Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation","volume":"121","author":"Lenassi","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1167\/iovs.11-8321","article-title":"Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa","volume":"52","author":"Bittner","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/tvst.8.3.36","article-title":"Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults with Retinal Dystrophies","volume":"8","author":"Barnes","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archopht.1984.01040030806021","article-title":"Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa","volume":"102","author":"Ross","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for leber congenital amaurosis caused by RPE65 mutations: Safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/ejhg.2016.99","article-title":"An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients","volume":"24","author":"Bonnet","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","article-title":"ISCEV standard for clinical pattern electroretinography (PERG): 2012 update","volume":"126","author":"Bach","year":"2013","journal-title":"Doc. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials: (2016 update)","volume":"133","author":"Odom","year":"2016","journal-title":"Doc. Ophthalmol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/3\/652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:48:11Z","timestamp":1760122091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/3\/652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,5]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["genes14030652"],"URL":"https:\/\/doi.org\/10.3390\/genes14030652","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,5]]}}}